Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cardiovascular system
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Magazines
Downloads
Videos

Refine by
Date

  • Older

Cardiovascular System Articles & Analysis

19 news found

New Offerings Released at Alfa Chemistry: Isoquinoline Alkaloids, Pyridine Alkaloids, and Phenylethylamine Alkaloids

New Offerings Released at Alfa Chemistry: Isoquinoline Alkaloids, Pyridine Alkaloids, and Phenylethylamine Alkaloids

They have strong biological activities and are able to constrict blood vessels in the cardiovascular system and protect against X-ray radiation. Hordenine and syfinerine are the two most common phenylethylamine alkaloids. ...

ByAlfa Chemistry


Kardiolytics’ VCAST Technology Offers Non-Invasive and Safe Solution for Functional Evaluation of Coronary Disease, According to Recent Study in Cardiovascular Engineering and Technology

Kardiolytics’ VCAST Technology Offers Non-Invasive and Safe Solution for Functional Evaluation of Coronary Disease, According to Recent Study in Cardiovascular Engineering and Technology

Our latest publication in Cardiovascular Engineering and Technology showcases the feasibility and functionality of our VCAST technology, a patented, AI-based medical system developed for non-invasive, clinical quantitative and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. ...

ByMedicalgorithmics S.A.


AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform

AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform

The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for Pompe disease, Parkinson’s disease and congestive heart failure. ...

ByBayer AG


Biomedical Company Gedeon Richter Partners with Health Education Platform Skrinings to Deliver Global, No-Cost Contraceptive Education

Biomedical Company Gedeon Richter Partners with Health Education Platform Skrinings to Deliver Global, No-Cost Contraceptive Education

The product portfolio of Richter covers many important therapeutic areas, including Women's Healthcare, Central Nervous System and Cardiovascular areas. Having the largest R&D unit in Central Eastern Europe, Richter's original research activity focuses on CNS disorders. ...

ByLongenesis


BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress due to COVID-19

BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress due to COVID-19

[Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for BCDA-04, a proprietary allogeneic mesenchymal cell (MSC) population that is Neurokinin-1 receptor positive ...

ByBiocardia, Inc.


T,C&A Lab Declares Capability of Biomedical Materials Testing

T,C&A Lab Declares Capability of Biomedical Materials Testing

” More specifically, the testing range of T,C&A Lab encompasses the following: l Repair materials for the skeletal-muscle system such as bones, teeth, joints, and tendons l Soft tissue materials such as skin, esophagus, respiratory tract, bladder and other l Cardiovascular system materials such as artificial heart valves, blood ...

ByAlfa Chemistry


Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and Aging

Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and Aging

Inflammation can contribute to the physical decline in Aging Frailty through multiple mechanisms, including detrimental effects on muscles, bone tissue, the immune system, cardiovascular function, and cognition. The necessity for identifying patients with Aging Frailty is well-acknowledged in the geriatric community, and the treatment of Aging Frailty and ...

ByLongeveron, Inc.


Magnolia Medical Appoints Industry Veteran, Joseph Bishop, as the Senior Vice President of Operations and Product Development

Magnolia Medical Appoints Industry Veteran, Joseph Bishop, as the Senior Vice President of Operations and Product Development

Before Onset, Bishop served as Vice President of Research and Development for Endologix, Inc. and held management and engineering positions at Radiance Medical Systems, CardioVascular Dynamics Inc., and Guidant (Advanced Cardiovascular Systems). ...

ByMagnolia Medical Technologies


Robocath successfully carries out Europe’s first remote robotic-assisted coronary angioplasty

Robocath successfully carries out Europe’s first remote robotic-assisted coronary angioplasty

Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces the successful completion of the first remote robotic-assisted coronary angioplasty in Europe. ...

ByRobocath


Robocath bolsters Strategic Committee with appointment of Chantal Le Chat as independent member

Robocath bolsters Strategic Committee with appointment of Chantal Le Chat as independent member

She will use her extensive knowledge of imaging systems to analyze strategic opportunities for promoting interoperability of equipments used in cath labs, in particular compatibility with R-One™, the first robotic platform, as well as future robotic generations. ...

ByRobocath


SaNOtize Obtains Health Canada Approval to Commence Phase II Trial for Potential COVID-19 Therapy

SaNOtize Obtains Health Canada Approval to Commence Phase II Trial for Potential COVID-19 Therapy

Ferid Murad, a recipient of the 1998 Nobel Prize in Physiology or Medicine for the discovery that nitric oxide acts as a signalling molecule in the cardiovascular system, and a member of the SaNOtize Board of Directors, said, "Nitric oxide is an incredibly versatile molecule that regulates almost everything in our body. ...

BysaNOtize Research and Development Corp.


Cyanotech Donates Protein Powder and Medical Supplies to Local Hospitals

Cyanotech Donates Protein Powder and Medical Supplies to Local Hospitals

Spirulina has been shown in multiple human clinical studies to help support the immune and cardiovascular system and provides numerous healthful antioxidants.* In addition to the protein shakes, Cyanotech has donated 45 boxes of gloves, 2 boxes of Tyvek® suits, and 1 box of respirator cleaning wipes to the Kona Community Hospital. ...

ByCyanotech Corporation


Flosonics Medical selected as a winner of Vale’s COVID-19 Challenge

Flosonics Medical selected as a winner of Vale’s COVID-19 Challenge

To help during the pandemic, the venture-backed startup developed a wearable Doppler ultrasound device capable of providing vital information about a COVID-19 patient’s cardiovascular system remotely via Bluetooth. The wireless functionality of FloPatch enables rapid deployment in most health care settings and is especially well-suited for resource-limited ...

ByFlosonics Medical


Invizius attracts £2.75m Pre-Series A investment

Invizius attracts £2.75m Pre-Series A investment

Invizius’s technology stems from research by the company’s co-founder and CTO, Dr Andy Herbert, and his team who believe it could reduce the huge death toll from cardiovascular disease among long-term dialysis patients. Currently life expectancy on dialysis is just one-third of normal, and half of patients die from cardiovascular complications. The ...

ByInvizius Limited


FFR-SEARCH Shows Clear Trend Towards Major Adverse Cardiac Events with Lower FFR

FFR-SEARCH Shows Clear Trend Towards Major Adverse Cardiac Events with Lower FFR

“The FFR-SEARCH observational registry is an important clinical investment for ACIST, which builds upon the existing clinical evidence supporting the use of our Navvus Rapid Exchange FFR Microcatheter and RXi System in a variety of applications,” said Brad Fox, president and CEO, ACIST Medical Systems, Inc. ...

ByACIST Medical Systems


Invizius secures £0.5m investment

Invizius secures £0.5m investment

Despite improvements in dialysis therapy, cardiovascular disease remains the leading cause of death for dialysis patients. Today, almost half of all dialysis patients die from cardiovascular complications, and life expectancy on dialysis is just one-third of that for the general population. The patient’s immune system sees the dialysis ...

ByInvizius Limited


Amsel Medical Corporation Announces First-In-Man Clinical Use of the Amsel Occluder Device at NYU Langone Medical Center

Amsel Medical Corporation Announces First-In-Man Clinical Use of the Amsel Occluder Device at NYU Langone Medical Center

On November 28, 2016, Amsel Medical Corporation announced Presentation of “A Novel Mechanical Closure Device for Left Atrial Appendage Orifice and Closure of Right Atrial Incision” at the International Conference for Innovations in Cardiovascular Systems (ICI) Meeting 2016, Israel. On October 27, 2015, Amsel Medical Corporation announced Filing of ...

ByAmsel Medical Corporation


21 Jun 2010: NIH-supported study finds novel pathway May open doors for new blood pressure treatments

The mice with the P450 generated more substances called epoxyeicosatrienoic acids or EETs, known for their role in protecting the cardiovascular system. EETs relax and dilate the blood vessels and fight inflammation. ...

ByNational Institute of Environmental Health Sciences (NIEHS)


EU scientific committee looks for mercury alternatives

EU scientific committee looks for mercury alternatives

High doses can be fatal to humans, but even relatively low doses can seriously affect the nervous, cardiovascular, immune and reproductive systems. In the presence of bacteria, mercury can change into methylmercury, its most toxic form. ...

ByHealth and Environment Alliance (HEAL)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT